Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation.

Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation. Abstract Text:

     morales Morales,

    Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation. Arterial hypertension is highly prevalent after renal transplantation and may contribute to the risk of cardiovascular disease. Also, arterial hypertension has been reported to be an independent risk factor for graft failure. Immunosuppressive drugs such as corticosteroids, cyclosporine and tacrolimus may be important contributing factors to post-transplant hypertension. Recent data from multicenter trials and from conversion studies (cyclosporine to tacrolimus) suggest that renal transplant patients under tacrolimus-based therapy showed less arterial hypertension compared with cyclosporine treated patients. New immunosuppressive drugs, including mycophenolate mofetil and rapamycin, are not nephrotoxic and they do not have any hypertensive effect. New immunosuppressive combinations including mycophenolate mofetil in a triple therapy regimen (associated with corticosteroids and cyclosporine) can reduce blood pressure so that corticosteroids can be stopped or cyclosporine reduced or even eliminated. Non-nephrotoxic regimens using rapamycin (sirolimus) as basic immunosuppression, associated with azathioprine or mycophenolate mofetil, could reduce the incidence of post-transplant arterial hypertension. Also, in renal transplant patients initially immunosuppressed with rapamycin, cyclosporine and corticosteroids, after the elimination of CSA, a lower blood pressure is achieved. In summary, new protocols with mycophenolate mofetil and/or rapamycin may permit several combinations that offer important alternatives to classical immunosuppressive regimens to reduce the incidence and clinical impact of arterial hypertension after renal transplantation.

    Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation. Publishing Authors By Initials

    jm moralesJM Morales,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Kidney international. Supplement

    VOLUME:

    Page Numbers: 81-7

    Journal Abbreviation: Kidney Int. Suppl.

    ISSN: 0098-6577

    DAY: 4

    MONTH: Dec

    YEAR: 2002

    Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7508622

    Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation.

    AFFILIATION: Nephrology Department. Hospital 12 de Octubre, Madrid, Spain.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Kidney Int Suppl

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News